Magnus Foldal Berle's picture

Magnus Foldal Berle

Associate Professor
  • E-mailMagnus.Berle@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2022). Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature. Cancer Genomics & Proteomics. 130-144.
  • Show author(s) (2019). The effect of WnT pathway modulators on human iPSC-derived pancreatic beta cell maturation. Frontiers in Endocrinology. 1-13.
  • Show author(s) (2018). Novel protein signatures suggest progression to muscular invasiveness in bladder cancer. PLOS ONE. 1-15.
  • Show author(s) (2017). Indre tarmbrokk. Tidsskrift for Den norske legeforening.
  • Show author(s) (2016). Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Proteomics. 1154-1165.
  • Show author(s) (2014). In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Molecular & Cellular Proteomics. 3152-3163.
  • Show author(s) (2013). Quantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients. Fluids and Barriers of the CNS.
  • Show author(s) (2011). Protein profiling reveals inter-individual protein homogeneity of arachnoid cyst fluid and high qualitative similarity to cerebrospinal fluid. Fluids and Barriers of the CNS.
  • Show author(s) (2010). Arachnoid cysts do not contain cerebrospinal fluid: A comparative chemical analysis of arachnoid cyst fluid and cerebrospinal fluid in adults. Cerebrospinal Fluid Research.
  • Show author(s) (2009). Discriminating Variable Test and Selectivity Ratio Plot: Quantitative Tools for Interpretation and Variable (Biomarker) Selection in Complex Spectral or Chromatographic Profiles. Analytical Chemistry. 2581-2590.
  • Show author(s) (2007). Pretreatment of mass spectral profiles: Application to proteomic data. Analytical Chemistry. 7014-7026.
  • Show author(s) (2007). Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. PROTEOMICS - Clinical Applications. 699-711.
Doctoral dissertation
  • Show author(s) (2013). Characterization of arachnoid cysts using clinical chemistry, gualitative and quantitative proteomiocs.
Academic chapter/article/Conference paper
  • Show author(s) (2018). Biochemistry – composition of and possible mechanisms for cyst fluid production.
  • Show author(s) (2008). Early diagnosis and biomarker discovery from mass spectral profiles: application to multiple sclerosis. Multiple Sclerosis. S285-S285.
  • Show author(s) (2008). Biomarker discovery from mass spectral profiles: A combined proteomics and multivariate analysis. European Journal of Pharmaceutical Sciences. S27-S27.
Academic literature review
  • Show author(s) (2006). Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis. Current Pharmaceutical Biotechnology. 147-158.
Article in business/trade/industry journal
  • Show author(s) (2021). En mann i 40-årene med mental og sirkulatorisk påvirkning etter falltraume. Tidsskrift for Den norske legeforening. 1-6.

More information in national current research information system (CRIStin)